Stock comparison
Bioventus
Mettler-Toledo International
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
BVS
Bioventus
Market cap
$628.7M
Sector
Healthcare
MTD
Mettler-Toledo International
Market cap
$22.29B
Sector
Healthcare
Overall winner
Mettler-Toledo International MTD
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | BVS | MTD | Winner |
|---|---|---|---|
| Warren Buffett | 36D | 69B | MTD |
| Benjamin Graham | 52D | 65B | MTD |
| Philip Fisher | 41D | 63C | MTD |
| Peter Lynch | 29F | 66B | MTD |
| Joel Greenblatt | 26F | 68B | MTD |
| Charlie Munger | 38D | 74B | MTD |
| Terry Smith | 34F | 70B | MTD |
Side-by-side metrics
| Metric | BVS | MTD |
|---|---|---|
| Market cap | $628.7M | $22.29B |
| P/E (TTM) | 25.0x | 25.3x |
| EV/EBIT | 12.0x | 21.6x |
| ROIC (TTM) | 11.77% | 36.09% |
| Gross margin | 67.78% | 57.79% |
| Net margin | 4.94% | 21.4% |
| Revenue CAGR 5y | 7.15% | 2.01% |
| EPS CAGR 5y | - | 6.12% |
| Debt / Equity | 0.1x | - |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
BVS leads on
- Revenue CAGR 5y7.15%vs 2.01%+72%
- EV/EBIT12.0xvs 21.6x+45%
- Gross margin67.78%vs 57.79%+15%
MTD leads on
- Debt / Equity-vs 0.1x+100%
- Market cap$22.29Bvs $628.7M+97%
- Net margin21.4%vs 4.94%+77%
- ROIC (TTM)36.09%vs 11.77%+67%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.